Heinz Schmidli
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Optimal Experimental Design Methods, Statistical Methods and Inference, Advanced Causal Inference Techniques, Statistical Methods and Bayesian Inference
Most-Cited Works
- → Robust meta‐analytic‐predictive priors in clinical trials with historical control information(2014)450 cited
- → Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts(2006)268 cited
- → Safety, Tolerability, and Efficacy of Everolimus in De Novo Liver Transplant Recipients: 12- and 36-Month Results(2006)140 cited
- → Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form(1998)139 cited
- → Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients(2007)128 cited
- → Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations(2006)126 cited
- → Population pharmacokinetics of imatinib mesylate in patients with chronic‐phase chronic myeloid leukaemia: results of a phase III study(2005)124 cited
- → Beyond Randomized Clinical Trials: Use of External Controls(2019)115 cited
- → Everolimus Therapeutic Concentration Range Defined from a Prospective Trial with Reduced-Exposure Cyclosporine in De Novo Kidney Transplantation(2004)98 cited
- → A faunistic approach to assess potential side-effects of genetically modified Bt -Corn on non-target arthropods under field conditions(2004)95 cited